• Patient Advocacy Groups Worldwide Plan Events to Mark Rare Disease Day, Feb. 28
  • Early Analysis Supports Eloctate Use in ITI Therapy for Severe Hemophilia A
  • The Ordinary Becomes the Extraordinary
  • Oklahoma Medical Research Foundation, Shanghai RAAS Partner on Hemophilia Therapy
  • South Korea Approves Shire’s Adynovate to Treat Hemophilia A Patients
  • Miniature Bleeding Model May Help Research into Wound Healing, Blood Disorders
  • The Hemo Mama Bear Olympics
  • Rare Disease Groups, Patients Differ on ‘Right to Try’ Bill Before US Congress
  • Hemophilia B Bleeding-control Treatment Rebinyn Available in the United States
  • Chris Bombardier Becomes First Hemophiliac to Climb 7 Continents’ Highest Peaks
  • Practice Makes Perfect
  • Catalyst to Present Multidose Data from CB 2679d for Hemophilia B at EAHAD Congress